Detalhe da pesquisa
1.
TMEM41B Is a Pan-flavivirus Host Factor.
Cell
; 184(1): 133-148.e20, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338421
2.
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
Cell
; 184(1): 120-132.e14, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382968
3.
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Proc Natl Acad Sci U S A
; 119(27): e2203820119, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759660
4.
Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein.
J Lipid Res
; 63(9): 100257, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931202
5.
A combinatorial strategy for treating KRAS-mutant lung cancer.
Nature
; 534(7609): 647-51, 2016 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338794
6.
Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET.
Bioconjug Chem
; 32(7): 1255-1262, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835770
7.
ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching.
J Proteome Res
; 17(11): 3681-3692, 2018 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295032
8.
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.
Pediatr Blood Cancer
; 62(5): 743-50, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307519
9.
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.
medRxiv
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260492
10.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
Sci Adv
; 10(13): eadm9859, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536921
11.
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation.
J Thorac Oncol
; 18(9): 1222-1232, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210008
12.
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Cancer Cell
; 41(1): 88-105.e8, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525973
13.
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer.
bioRxiv
; 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131623
14.
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
bioRxiv
; 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425844
15.
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.
Cell Rep
; 42(11): 113295, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889752
16.
Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
J Gen Virol
; 93(Pt 12): 2606-2613, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22971818
17.
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.
J Nucl Med
; 63(9): 1401-1407, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058323
18.
Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seq.
STAR Protoc
; 3(4): 101776, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313536
19.
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.
Clin Cancer Res
; 28(7): 1391-1401, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046060
20.
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Nat Cancer
; 3(10): 1260-1270, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941262